Peer-reviewedCC BYFrontiers in aging neuroscience
No evidence that serum metabolite slopes improve held-out prediction of clinical progression in the Alzheimer’s disease neuroimaging initiative
- 1Department of Health Sciences, Juniata College , , ,
Related
- Integration of neuroimaging signatures of aging and Alzheimer's with fluid biomarkers
- Clinical, neuroimaging, and longitudinal progression characteristics of GBA1-associated Parkinson's disease in a Northeast China cohort.
- Too early for LATE? Age at onset is associated with the clinical and neuroimaging expression of limbic-predominant age-related TDP-43 pathology in Alzheimer's disease
- Multimodal Characterization of APOE ε4-Associated Neurovascular Heterogeneity Using Retinal, Plasma, and Neuroimaging Biomarkers in Alzheimer's Disease.
- Different osteoarthritis progression rates within early-stage knee osteoarthritis: a retrospective cohort study using machine learning cluster analysis from the osteoarthritis initiative database.
BibTeX
@article{warrick2026evidence,
title = {{No evidence that serum metabolite slopes improve held-out prediction of clinical progression in the Alzheimer’s disease neuroimaging initiative}},
author = {Tia Warrick and Manali Misra and Stephen Kataria and Jahnavi Patel and Bhuvi Ajmera},
journal = {Frontiers in aging neuroscience},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13670211},
note = {CC BY},
}
RIS
TY - JOUR
TI - No evidence that serum metabolite slopes improve held-out prediction of clinical progression in the Alzheimer’s disease neuroimaging initiative
AU - Tia Warrick
AU - Manali Misra
AU - Stephen Kataria
AU - Jahnavi Patel
AU - Bhuvi Ajmera
PY - 2026
DA - 2026/10/19
JO - Frontiers in aging neuroscience
UR - https://europepmc.org/article/PMC/PMC13670211
SN - 1663-4365
ER -